3 Years Investing at LDV Capital: Insights from Sourcing, Evaluating & Partnering with Early-Stage Deep Tech Founders

3 Years Investing at LDV Capital: Insights from Sourcing,  Evaluating & Partnering with Early-Stage Deep Tech Founders

In September 2021, Ash Cleary began his venture capital journey by joining Evan Nisselson and our LDV Capital team as an Analyst, investing out of Fund III as part of a two-year program. After successfully completing the program, Ash was promoted to Associate and now invests out of LDV Capital's fourth fund.

Check out his insights and reflections on the past three years—working with the team and collaborating with brilliant deep tech entrepreneurs worldwide, building businesses powered by visual technology and artificial intelligence.

Read More

Partnering with VitVio to Deliver Real-Time AI Visual Tracking In Hospital Operating Theatres to Increase Efficiencies

Partnering with VitVio to Deliver Real-Time AI Visual Tracking In Hospital Operating Theatres to Increase Efficiencies

We are excited to partner and invest in the brilliant VitVio team. They are building an AI-driven computer vision platform designed to enhance the safety and efficiency of hospital operating theaters.

We at LDV Capital led their $2M pre-seed round with participation from Bek Ventures (ex-Earlybird), Tiny Supercomputer Investment Company, and angel investors.

VitVio has also announced their pilot program with the Royal Orthopaedic Hospital (ROH), one of the UK's three leading medical institutions in orthopedic care and “one of the best hospitals in the world.”

Read More

Visual Technologies Are Fueling the Transition To a Circular Economy

Visual Technologies Are Fueling the Transition To a Circular Economy

LDV Capital's Evan Nisselson and Ash Cleary cover topics ranging from spectroscopy and nanomaterials to enhance food and agricultural production, to renewable energy forecasting and grid management, and predictive digital twins for the supply chain.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.

Read More

Meta’s Matt Uyttendaele on AI for Material Discovery

Meta’s Matt Uyttendaele on AI for Material Discovery

Matt Uyttendaele is the director of the AI for Chemistry group at Meta. His group applies machine learning to material discovery for several applications: clean hydrogen, sorbents for direct air capture, and next-generation displays. In 2024, we were honored to have him speak at our Annual General Meeting about a new application of AI that he has been working on for the last few years and how it relates to his career in visual technologies.

Read More

Visual Tech Advancements in Life Sciences & Biotech Paving the Way for Longer and Healthier Lives

Visual Tech Advancements in Life Sciences & Biotech Paving the Way for Longer and Healthier Lives

As the biotech industry heavily relies on data filtering, analysis, and sharing, visual technologies play a critical role in detecting and imaging biological systems. This paves the way for the future of life sciences tools, enabling next-generation therapeutics, biomanufacturing, and longevity. At our 10th Annual LDV Vision Summit earlier this year, a panel of experts delved into these topics and explored various critical aspects shaping the future of biotechnology. Check out their insights.

Read More

Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

We at LDV Capital celebrated our 10th LDV Vision Summit Anniversary! People from over 30 countries were part of our premier global gathering in visual tech & AI. We were thrilled to welcome speakers from Sequoia Capital, Wellville, Generate:Biomedicines, DCVC Bio, Princeton University, Stanford University, University of California, Nobias Therapeutics, Snap, Future Ventures, Meta, Axios and more. Two of our LDV Capital portfolio companies presented as well: Synthesia and Sonus Microsystems.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

On March 21, at our 10th Annual LDV Vision Summit, Evan Nisselson, Founder and General Partner at LDV Capital, will speak with Dr. Molly Gibson – Co-Founder and Chief Strategy and Innovation Officer at Generate:Biomedicines. They will discuss how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials, and more. This will have a tremendous impact on business and society. 

In the lead-up to the Summit, Evan had the privilege of asking Dr. Gibson a few questions.

Read More

LDV Capital Raised Fourth Fund To Continue Investing in People Building Businesses Powered by Visual Technologies and Artificial Intelligence

We are pleased to announce that we have raised our fourth LDV Capital fund with $31M. We will continue investing in the same unique thesis that has not changed since founding LDV Capital in 2012. The majority of data our brains analyze is visual so the majority of data that AI will analyze will be visual as well. Visual data and visual technologies are critical for the success of artificial intelligence horizontally across all sectors.

Read More

“The Difference Is – Now The Whole World Is Paying Attention To AI,” Says Prof. Serge Belongie

“The Difference Is – Now The Whole World Is Paying Attention To AI,” Says Prof. Serge Belongie

As we approach the 10th Annual LDV Vision Summit, we thought it fitting to pose a few burning questions to Serge Belongie, a professor of Computer Science at the University of Copenhagen, the head of the Danish Pioneer Centre for Artificial Intelligence and LDV Capital Expert in Residence. We delved into his experiences as a prominent figure in AI and sought his insights on the present landscape of visual technologies. Additionally, we explored his thoughts on the prospects available to researchers aiming to bring their work to market and impact humanity at large.

Read More

LDV Community Helping Entrepreneurs Succeed For 11 Years

LDV Community Helping Entrepreneurs Succeed For 11 Years

Thrilled to present a selection of photos capturing moments from our recent invite-only "Happy Hour" event, held in New York City. This event brought together outstanding technology innovators, serial entrepreneurs, deep tech researchers, and investors from within the vibrant New York tech ecosystem.

Read More

Tackling the Climate Crisis by Detecting, Verifying & Classifying Wildfires in Real-Time With the Help of AI

Tackling the Climate Crisis by Detecting, Verifying & Classifying Wildfires in Real-Time With the Help of AI

The climate crisis is resulting in an increased frequency and intensity of natural disasters, and society needs new tools to be able to cope and adapt. Sonia Kastner is the CEO & founder of Pano AI, the leader in wildfire early detection and intelligence. Pano combines advanced hardware, AI and computer vision to automatically detect, verify and classify wildfire events in real-time. 

At our 9th Annual LDV Vision Summit, Sonia shared how visual technologies are at the crux of disaster mitigation solutions to help tackle the climate crisis.

Read More

Since 2012 - Timeline of Investing In People Building Businesses Powered by Visual Tech & AI

Since 2012 - Timeline of Investing In People Building Businesses Powered by Visual Tech & AI

Last year, we celebrated 10 years of investing in people building businesses powered by visual tech & AI, but it’s just the beginning! Visual technology innovations will continue to be the crux of automation for decades and beyond. Computer vision, machine learning and AI will be the key enablers for innovation in healthcare, precision medicine, manufacturing, construction, agriculture, sustainability, and many more industries.

Read More

Thank You for Being a Vital Part of Our 9th Annual LDV Vision Summit!

Thank You for Being a Vital Part of Our 9th Annual LDV Vision Summit!

At our 9th Annual LDV Vision Summit, we welcomed top technologists, investors, and entrepreneurs to discuss cutting-edge computer vision, machine learning and AI solutions to improve the world we live in.

About a thousand people tuned in from all around the world to listen to expert speakers from DeepMind, Mural, Snap, BioAge, Synthesia, Salesforce, Harvard Medical School, Insight Partners, Useful Sensors, Conviction, Niels Bohr Institute, Air Street Capital, Uizard, Pano, Humanity, Northeastern University, Seedcamp, Forbes, and more.

Read More

Generative AI As A Utility Will Empower SaaS Businesses

Generative AI As A Utility Will Empower SaaS Businesses

We at LDV Capital have been investing in AI for over 10 years to date, and have made 7 investments in teams building businesses leveraging Generative AI since 2018. We believe that this technology has significant commercial value as a utility that will empower SaaS businesses to disrupt legacy enterprises. Check out this article to learn more and see some examples of exponentially growing commercial applications in content creation, biotech and more.

Read More

Partnering With ImVitro To Increase Successful IVF Fertility Pregnancies by Leveraging Computer Vision & AI

Partnering With ImVitro To Increase Successful IVF Fertility Pregnancies by Leveraging Computer Vision & AI

We at LDV Capital are thrilled to partner with Dr. Alexandra Boussommier and the brilliant team at ImVitro, a company behind the B2B SaaS platform Embryoly that applies computer vision and artificial intelligence to the IVF fertility imaging process. They are focused on increasing successful pregnancies, quality control and transparency along the entire IVF workflow for patients and improving clinics' productivity.

Read More